{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:27:22Z","timestamp":1793467642973,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG2K0371-3"],"award-info":[{"award-number":["CMRPG2K0371-3"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2023\/R\/1444"],"award-info":[{"award-number":["PSAU\/2023\/R\/1444"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST-113-2320-B-182-024-MY3"],"award-info":[{"award-number":["MOST-113-2320-B-182-024-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.intimp.2024.113486","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T11:59:27Z","timestamp":1730289567000},"page":"113486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"P2","title":["Topical delivery of bioactive compounds from Cortex Dictamni alleviates atopic dermatitis-like lesion by inhibiting the activation of keratinocytes, macrophages, and basophils: Dictamnine versus fraxinellone"],"prefix":"10.1016","volume":"143","author":[{"given":"Wei-Ling","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Chun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alshetaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hsuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sien-Hung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-You","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113486_b0005","article-title":"Assessment and management of atopic dermatitis in primary care settings: a systematic review","volume":"15","author":"Alqahtani","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.intimp.2024.113486_b0010","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.yapd.2023.03.006","article-title":"Update on atopic dermatitis","volume":"70","author":"Kellogg","year":"2023","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.intimp.2024.113486_b0020","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jid.2016.08.022","article-title":"Increasing comorbidities suggest that atopic dermatitis is a systemic disorder","volume":"137","author":"Brunner","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2024.113486_b0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.18176\/jiaci.0906","article-title":"Updated review on treatment of atopic dermatitis","volume":"33","author":"Armario-Hita","year":"2023","journal-title":"J. Invest. Allergol. Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111741","article-title":"A comprehensive review of natural products against atopic dermatitis: flavonoids, alkaloids, terpenes, glycosides and other compounds","volume":"140","author":"Wu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113486_b0035","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/ptr.7007","article-title":"Dictamnine is an effective anti-anaphylactoid compound acting via the MrgX2 receptor located on mast cells","volume":"35","author":"Liu","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2024.113486_b0040","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/jpp\/rgab141","article-title":"The traditional uses, phytochemistry, pharmacology and toxicology of Dictamnus dasycarpus: a review","volume":"73","author":"Qin","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113486_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153453","article-title":"Anti-atopic dermatitis effects of dictamni cortex: studies on in vitro and in vivo experimental models","volume":"82","author":"Chen","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2024.113486_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.116023","article-title":"Network pharmacology-based analysis to explore the therapeutic mechanism of Cortex Dictamni on atopic dermatitis","volume":"304","author":"Yang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.113486_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110142","article-title":"The formulae and biologically active ingredients of Chinese herbal medicines for the treatment of atopic dermatitis","volume":"127","author":"Yan","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113486_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2020.112260","article-title":"Anti-inflammatory quinolone alkaloids from the root bark of Dictamnus dasycarpus","volume":"172","author":"Gao","year":"2020","journal-title":"Phytochemistry"},{"key":"10.1016\/j.intimp.2024.113486_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115368","article-title":"Dictamnine ameliorates chronic itch in DNFB-induced atopic dermatitis mice via inhibiting MrgprA3","volume":"208","author":"Yang","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113486_b0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1248\/bpb.b23-00436","article-title":"Dictamnine ameliorates DNFB-induced atopic dermatitis like skin lesions in mice by inhibiting M1 macrophage polarization and promoting autophage","volume":"47","author":"Huang","year":"2024","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2024.113486_b0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.intimp.2019.01.043","article-title":"Fraxinellone inhibits inflammatory cell infiltration during acute pancreatitis by suppressing inflammasome activation","volume":"69","author":"Kim","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.113486_b0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jep.2014.10.027","article-title":"Acute and sub-chronic oral toxicity profiles of the aqueous extract of Cortex Dictamni in mice and rats","volume":"158","author":"Wang","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.113486_b0085","doi-asserted-by":"crossref","first-page":"03603","DOI":"10.1016\/j.jprot.2019.103603","article-title":"Integration of transcriptomics and metabolomics profiling reveals the metabolic pathways affected in dictamnine-induced hepatotoxicity in mice","volume":"213","author":"Li","year":"2020","journal-title":"J. Proteomics"},{"key":"10.1016\/j.intimp.2024.113486_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28135045","article-title":"Exploring the mechanism of hepatotoxicity induced by Dictamnus dasycarpus based on network pharmacology, molecular docking and experimental pharmacology","volume":"28","author":"Gao","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.113486_b0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.taap.2018.12.012","article-title":"Dictamnine-induced hepatotoxicity in mice: the role of metabolic activation of furan","volume":"364","author":"Shi","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113486_b0100","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1021\/acs.chemrestox.0c00141","article-title":"Cytochrome P450-mediated bioactivation: implication for the liver injury induced by fraxinellone, a bioactive constituent from Dictamni Cortex","volume":"33","author":"Zhou","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.intimp.2024.113486_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154778","article-title":"Difference in hepatotoxicity of furan-containing components in cortex dictamni correlates the efficiency of their metabolic activation","volume":"114","author":"Pan","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.intimp.2024.113486_b0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s13555-023-01081-0","article-title":"Cutaneous components leading to pruritus, pain, and neurosensitivity in atopic dermatitis: a narrative review","volume":"14","author":"St\u00e4nder","year":"2024","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.intimp.2024.113486_b0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejpb.2016.05.025","article-title":"Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: the skin absorption assessment","volume":"105","author":"Liu","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.intimp.2024.113486_b0120","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/all.15967","article-title":"Forsythia velutina Nakai extract: a promising therapeutic option for atopic dermatitis through multiple cell type modulation","volume":"79","author":"Kwon","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2024.113486_b0125","doi-asserted-by":"crossref","first-page":"16-e5","DOI":"10.1111\/vde.12351","article-title":"A review of the roles of keratinocyte-derived cytokines and chemokines in the pathogenesis of atopic dermatitis in humans and dogs","volume":"28","author":"Asahina","year":"2017","journal-title":"Vet. Dermatol."},{"key":"10.1016\/j.intimp.2024.113486_b0130","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.jid.2023.04.005","article-title":"Assessment of treatment-relevant immune biomarkers in psoriasis and atopic dermatitis: toward personalized medicine in dermatology","volume":"143","author":"Mortlock","year":"2023","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2024.113486_b0135","doi-asserted-by":"crossref","first-page":"2249982","DOI":"10.1002\/eji.202249982","article-title":"Epithelial-immune cell interactions in allergic diseases","volume":"54","author":"Albrecht","year":"2024","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0140","article-title":"Anti-allergic and anti-inflammatory effects of kuwanon G and morusin on MC\/9 mast cells and HaCaT keratinocytes","volume":"24","author":"Jin","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.intimp.2024.113486_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197348","article-title":"Chrysin inhibits NF-\u03baB-dependent CCL5 transcription by targeting I\u03baB kinase in the atopic dermatitis-like inflammatory microenvironment","volume":"21","author":"Yeo","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113486_b0150","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jaci.2022.11.023","article-title":"Skin TARC\/CCL17 increase precedes the development of childhood atopic dermatitis","volume":"151","author":"Halling","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0155","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1007\/s00018-016-2297-8","article-title":"Negative feedback regulation of the ERK1\/2 MAPK pathway","volume":"73","author":"Lake","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2024.113486_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.749806","article-title":"JNK mediates differentiation, cell polarity and apoptosis during amphioxus development by regulatory actin cytoskeleton dynamics and ERK signaling","volume":"9","author":"Somorjai","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2024.113486_b0165","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00204-023-03492-6","article-title":"Understanding the molecular mechanisms of statin pleiotropic effect","volume":"97","author":"German","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.intimp.2024.113486_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells12242793","article-title":"Cytokines and epidermal lipid abnormalities in atopic dermatitis: a systematic review","volume":"12","author":"Upadhyay","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.113486_b0175","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jdv.19153","article-title":"IL-1\u03b1\/\u03b2 and IL-18 profiles and their impact on claudin-1, loricrin and filaggrin expression in patients with atopic dermatitis","volume":"37","author":"Michaelidou","year":"2023","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2024.113486_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21155382","article-title":"Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis","volume":"21","author":"Furue","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113486_b0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/ACI.0000000000000376","article-title":"Atopic dermatitis phenotypes and the need for personalized medicine","volume":"17","author":"Cabanillas","year":"2017","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40272-022-00499-x","article-title":"Recent developments and advances in atopic dermatitis: a focus on epidemiology, pathophysiology, and treatment in the pediatric setting","volume":"24","author":"Eichenfield","year":"2022","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.intimp.2024.113486_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116073","article-title":"Skin delivery of synthetic benzoyl pterostilbenes mitigates atopic dermatitis-like inflammation through the inhibition of keratinocyte and macrophage activation","volume":"170","author":"Tang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113486_b0200","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/942375","article-title":"Role of macrophages in the pathogenesis of atopic dermatitis","volume":"2013","author":"Kasraie","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.intimp.2024.113486_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116026","article-title":"Hinokitiol as a modulator of TLR4 signaling and apoptotic pathways in atopic dermatitis","volume":"170","author":"Tai","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113486_b0210","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5114\/pdia.2014.40920","article-title":"Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis","volume":"31","author":"Nedoszytko","year":"2014","journal-title":"Postep. Dermatol. Allergol."},{"key":"10.1016\/j.intimp.2024.113486_b0215","article-title":"Anti-inflammatory limonoids from Cortex Dictamni","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.intimp.2024.113486_b0220","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2023.04.057","article-title":"Emerging treatments for itch in atopic dermatitis: a review","volume":"89","author":"Labib","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2024.113486_b0225","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2019.06.016","article-title":"Pruritus in allergy and immunology","volume":"144","author":"Yang","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.923495","article-title":"Roles of mast cells in cutaneous diseases","volume":"13","author":"Numata","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0235","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202250359","article-title":"Mast cells in type 2 skin inflammation: maintenance and function","volume":"53","author":"Keith","year":"2023","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0240","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081187","article-title":"Mast cells as a target-a comprehensive review of recent therapeutic approaches","volume":"12","author":"Baran","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.113486_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/cells10082170","article-title":"Roles of IgE and histamine in mast cell maturation","volume":"10","author":"Tanaka","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.intimp.2024.113486_b0250","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tox.2017.06.008","article-title":"Quantitative structure-skin permeability relationships","volume":"387","author":"Tsakovska","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.intimp.2024.113486_b0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0887-2333(02)00003-6","article-title":"Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption","volume":"16","author":"Moss","year":"2002","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.intimp.2024.113486_b0260","doi-asserted-by":"crossref","DOI":"10.3390\/life13061419","article-title":"Atopic dermatitis: disease features, therapeutic options, and a multidisciplinary approach","volume":"13","author":"Lugovi\u0107-Mihi\u0107","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.intimp.2024.113486_b0265","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ijpharm.2016.10.042","article-title":"In vivo skin penetration of macromolecules in irritant contact dermatitis","volume":"515","author":"Abdel-Mottaleb","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2024.113486_b0270","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijpharm.2015.12.006","article-title":"What is the discrepancy between drug permeation into\/across intact and diseased skins? Atopic dermatitis as a model","volume":"497","author":"Fang","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2024.113486_b0275","first-page":"1235","article-title":"Establishment of mouse models to mimic human atopic dermatitis by repeated application of haptens","volume":"30","author":"Nakata","year":"2021","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.intimp.2024.113486_b0280","first-page":"267","article-title":"Atopic dermatitis: a disease of altered skin barrier and immune dysregulation","volume":"245","author":"Kim","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.113486_b0285","first-page":"581","article-title":"Mouse models of atopic dermatitis: a translational perspective for developing new therapies","volume":"150","author":"Kawakami","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1028694","article-title":"Potential biomarkers of atopic dermatitis","volume":"9","author":"Yu","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2024.113486_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087021","article-title":"The role of mast cells in the induction and maintenance of inflammation in selected skin diseases","volume":"24","author":"Wo\u017aniak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113486_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118906","article-title":"TRPA21 deficiency alleviates inflammation of atopic dermatitis by reducing macrophage infiltration","volume":"266","author":"Zeng","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2024.113486_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109743","article-title":"Polyozellin alleviates atopic dermatitis-like inflammatory and pruritic responses in activated keratinocytes and mast cells","volume":"122","author":"Jeong","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2024.113486_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612811","article-title":"Furoquinoline alkaloids: insights into chemistry, occurrence, and biological properties","volume":"24","author":"Szewczyk","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113486_b0315","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1055\/s-2006-947166","article-title":"Solar simulator-induced phototoxicity of the furoquinoline alkaloid dictamnine compared to 8-methoxypsoralen and 5-methoxypsoralen","volume":"72","author":"Schempp","year":"2006","journal-title":"Planta Med."},{"key":"10.1016\/j.intimp.2024.113486_b0320","article-title":"Topical medications for atopic dermatitis and effects on increasing lymphoma risks","volume":"15","author":"Bocklud","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.intimp.2024.113486_b0325","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.anai.2022.01.012","article-title":"Optimizing emollient therapy for skin barrier repair in atopic dermatitis","volume":"128","author":"Elias","year":"2022","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.intimp.2024.113486_b0330","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1684\/ejd.2013.2060","article-title":"Comparative histology and immunohistochemistry of porcine versus human skin","volume":"23","author":"Debeer","year":"2013","journal-title":"Eur. J. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924020083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924020083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:34:19Z","timestamp":1736303659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924020083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":66,"alternative-id":["S1567576924020083"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113486","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical delivery of bioactive compounds from Cortex Dictamni alleviates atopic dermatitis-like lesion by inhibiting the activation of keratinocytes, macrophages, and basophils: Dictamnine versus fraxinellone","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113486"}}